Normal and tumor-derived organoids as a drug screening platform for tumor-specific drug vulnerabilities

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Camilla Calandrini, Jarno Drost

Journal title: STAR Protocols

Journal number: Volume 3, Issue 1, 18 March 2022

Journal publisher: Cell Press

Published year: 2022

DOI identifier: 10.1016/j.xpro.2021.101079

ISSN: 2666-1667